A Multi-Analyte-Profile (MAP) combining analytes most commonly associated with cardiovascular disease. Like all Myriad RBM MAPs, it is used to identify useful patterns indicative of the effects of either disease or therapeutic intervention. Myriad RBM’s MAP approach provides investigators with a reliable platform and quantitative immunoassay data that can help discern biomarker patterns in a cost-effective, efficient process.
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|200 µL||700 µL|